美好医疗 (301363)
Mehow Innovative Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 56887.12
- Circulating A-Shares(W): 37320.30
- Earnings Per Share(RMB): 0.3700
- Net Assets Per Share(RMB): 6.5076
- Operating Revenue(W RMB): 119447.41
- Total Profit(W RMB): 23779.89
- Net Profit Attributable to Parent(W RMB): 20820.23
- Net Profit Growth Rate(%): -19.25
- Weighted Return on Equity(%): 5.7900
- Operating Cash Flow Per Share(RMB): 0.3900
- Undistributed Profit Per Share(RMB): 2.7435
- Capital Reserve Per Share(RMB): 2.5912
2. Main Business
The main business covers:
- Design, development, manufacturing and sales of precision components and products for medical devices.
3. Company Basic Information
- Company Name: Shenzhen Mehow Creative Medical Technology Co., Ltd.
- Listing Date: 2022-10-12
- Industry: Special Purpose Equipment Manufacturing
- Address: Building B, Xinzhongqiao Industrial Park, No. 3 Baolong 6th Road, Baolong Street, Longgang District, Shenzhen, Guangdong Province
- Website: www.mehow.com
- Company Profile: On November 6, 2019, approved by the shareholders' meeting of Mehow Limited, Mehow Limited was restructured into a joint stock company based on the audited parent company net assets of 490.9065 million yuan as of August 31, 2019, converted into 103.6 million shares, with a par value of 1 yuan per share, totaling a share capital of 103.6 million yuan. The net assets exceeding the registered capital of 387.3065 million yuan were recorded as capital reserve. On November 22, 2019, Tianjian Certified Public Accountants issued the "Capital Verification Report" (Tianjian Yan [2019] 3-75), verifying this change. On November 22, 2019, the company held its founding meeting, reviewed and passed relevant resolutions for establishing the joint stock company, and signed new articles of association. On the same day, all shareholders of the company signed the "Sponsor Agreement of Shenzhen Mehow Creative Medical Technology Co., Ltd.". On November 27, 2019, the Shenzhen Market Supervision Administration approved and filed this change, issued a new business license, with the unified social credit code 914403005586534068.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Ningbo Gongcheng Yongyi Venture Capital Partnership (Limited Partnership) | General Legal Person | 1065.64 | 6.82 |
| 2 | Guotai Juxin Value Advantage Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 591.79 | 3.79 |
| 3 | Huabao CSI Medical ETF | Fund | 481.27 | 3.08 |
| 4 | Shenwan Lingxin Fund - Everbright Bank - Shenwan Lingxin Changhong No.1 Collective Asset Management Plan | Asset Management Plan | 430.80 | 2.76 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 371.34 | 2.38 |
| 6 | Guotai Jinniu Innovation and Growth Hybrid Securities Investment Fund | Fund | 361.79 | 2.32 |
| 7 | Penghua Emerging Industries Hybrid Securities Investment Fund | Fund | 357.58 | 2.29 |
| 8 | Bosera Healthcare Industry Hybrid Securities Investment Fund Class A | Fund | 200.95 | 1.29 |
| 9 | Guotai Xingze Preferred One-Year Holding Hybrid Securities Investment Fund Class A | Fund | 186.79 | 1.20 |
| 10 | Guotai Pharmaceutical and Health Equity Securities Investment Fund Class A | Fund | 164.06 | 1.05 |
5. Concept Sectors
- Intelligent Machines
- Consumer Electronics
- CXO Concept
- Brain-Computer Interface
- Weight Loss Drugs
- PEEK Materials
- Margin Trading & Securities Lending
- Overseas Business
- Funds Reducing Holdings
- ChiNext 300
- ChiNext Innovation
- ChiNext Quality
- ChiNext Healthcare
- ChiNext 200
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information